Among the potential adverse effects of breast cancer treatment, chemotherapy-related
cognitive impairment (CRCI) has gained increased attention in the past years. In this review …

Cognitive dysfunction has been one of the most reported and studied adverse effects of
cancer treatment, but, for many years, it was overlooked by the medical community …

Alumunium usage and toxicity has been a global concern especially an increased use of
nanoparticulated aluminum (Al-NPs) products from the environment and the workplace. Al …

Naringin is a plant flavonoid of huge medicinal importance. It is synthesized by the
phenylpropanoid pathway via seven enzyme catalysed steps from phenylalanine to prunin …

Chemotherapeutic-related toxicity exacerbates the increasing death rate among cancer
patients, necessitating greater efforts to find a speedy solution. An in vivo assessment of the …

Chemotherapy-induced cognitive impairment (CICI) is a debilitating condition resulting from
chemotherapy administration for cancer treatment. CICI is characterised by various cognitive …

Objectives Alzheimer's disease (AD) is a neurodegenerative disease characterized by
cognitive impairment. This situation imposes a great burden on individuals, both …

Background Doxorubicin (DOX) is a broad-spectrum antitumor drug while its use is limited
nowadays due to its neurobiological side effects associated with depression. Bone marrow …

Doxorubicin (DOX) is an anthracycline antibiotic and a quinone-containing
chemotherapeutic drug used for various types of cancers. However, as with most anticancer …

Background Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the
mammalian brain and is a non-proteinogenic amino acid. Doxorubcin (DOX) or adriamycin …